iSTAR Medical SA
iSTAR Medical SA, headquartered in Belgium, is a pioneering company in the ophthalmic medical device industry, specialising in innovative solutions for glaucoma treatment. Founded in 2010, iSTAR Medical has made significant strides with its flagship product, the MINIject, a minimally invasive implant designed to lower intraocular pressure effectively. The company operates primarily in Europe and has expanded its reach to various international markets, establishing a strong presence in the ophthalmology sector. iSTAR Medical is recognised for its commitment to advancing patient care through unique, evidence-based technologies that enhance surgical outcomes. With a focus on innovation and quality, iSTAR Medical continues to solidify its position as a leader in the field, contributing to improved treatment options for glaucoma patients worldwide.
DitchCarbon Score
How does iSTAR Medical SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
iSTAR Medical SA's score of 14 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
iSTAR Medical SA's reported carbon emissions
iSTAR Medical SA, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that iSTAR Medical SA may still be in the early stages of developing its climate commitments or reporting framework. As the company operates within the medical technology sector, it is essential for iSTAR Medical SA to consider establishing clear sustainability goals and emissions reduction strategies in line with industry standards. This could include setting Science-Based Targets (SBTi) or participating in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability regarding their environmental impact. In summary, while iSTAR Medical SA has not yet disclosed any emissions data or climate commitments, there is an opportunity for the company to engage in meaningful climate action and reporting in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
iSTAR Medical SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
